drugset / Trial / NCT04073433

Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (MT-2)

NCT04073433

Phase 1 Withdrawn Resilient Pharmaceuticals
NaSingle-groupOpen-labelBasic science

Summary

The goal of this clinical trial is to study MDMA-assisted therapy in healthy volunteers and provide training of therapists. The main question it aims to answer is: Does MDMA-assisted therapy result in personal and professional benefits? Participants will have a non-drug preparatory session prior to each experimental session and an integrative session after each experimental session.

Timeline

Start
2024-12
Primary completion
2025-12
Completion
2025-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Midomafetamine Unknown 120 mg

Indications

No indication recorded.